Discussion and Q&A - Vienna 2024 - ERS Respiratory Channel

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Advances in short regimens for treating drug-susceptible and drug-resistant tuberculosis

Chair(s): Onno Akkerman, James D. Chalmers

Session type: Symposium

Discussion and Q&A

EVENTS HOME

Previous presentation

Next presentation

Session content

Short-course regimens for drug-susceptible tuberculosis

Carla Winston

Replay

Slides

Short-course regimens for rifampicin-resistant tuberculosis

Jussi Saukkonen

Replay

Slides

Discussion and Q&A

Replay

Session aims

To discuss the most up-to-date data on the short-course regimens for drug-susceptible and drug-resistant tuberculosis.

The ERS Congress 2024, Vienna